114 related articles for article (PubMed ID: 35224623)
1. Human leukocyte antigen mismatch on lung transplantation outcomes.
Firoz A; Kashem M; Zhao H; Geier S; Toyoda Y
Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35224623
[TBL] [Abstract][Full Text] [Related]
2. Influence of human leukocyte antigen mismatching on bronchiolitis obliterans syndrome in lung transplantation.
Hayes D; Black SM; Tobias JD; Kopp BT; Kirkby SE; Mansour HM; Whitson BA
J Heart Lung Transplant; 2016 Feb; 35(2):186-94. PubMed ID: 26496787
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
[TBL] [Abstract][Full Text] [Related]
4. The impact of HLA-DR mismatch status on retransplant-free survival and bronchiolitis obliterans syndrome‒free survival among sensitized lung transplant recipients.
Courtwright AM; Kamoun M; Kearns J; Diamond JM; Golberg HJ
J Heart Lung Transplant; 2020 Dec; 39(12):1455-1462. PubMed ID: 33071182
[TBL] [Abstract][Full Text] [Related]
5. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.
Sundaresan S; Mohanakumar T; Smith MA; Trulock EP; Lynch J; Phelan D; Cooper JD; Patterson GA
Transplantation; 1998 Mar; 65(5):648-53. PubMed ID: 9521198
[TBL] [Abstract][Full Text] [Related]
6. Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations.
Quantz MA; Bennett LE; Meyer DM; Novick RJ
J Heart Lung Transplant; 2000 May; 19(5):473-9. PubMed ID: 10808155
[TBL] [Abstract][Full Text] [Related]
7. Relative impact of human leukocyte antigen mismatching and graft ischemic time after lung transplantation.
Brugière O; Thabut G; Suberbielle C; Reynaud-Gaubert M; Thomas P; Pison C; Saint Raymond C; Mornex JF; Bertocchi M; Dromer C; Velly JF; Stern M; Philippe B; Dauriat G; Biondi G; Castier Y; Fournier M
J Heart Lung Transplant; 2008 Jun; 27(6):628-34. PubMed ID: 18503962
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches.
van den Berg JW; Hepkema BG; Geertsma A; Koëter GH; Postma DS; de Boer WJ; Lems SP; van der Bij W
Transplantation; 2001 Feb; 71(3):368-73. PubMed ID: 11233895
[TBL] [Abstract][Full Text] [Related]
9. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
[TBL] [Abstract][Full Text] [Related]
10. HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction.
Girnita AL; Duquesnoy R; Yousem SA; Iacono AT; Corcoran TE; Buzoianu M; Johnson B; Spichty KJ; Dauber JH; Burckart G; Griffith BP; McCurry KR; Zeevi A
Am J Transplant; 2005 Jan; 5(1):131-8. PubMed ID: 15636621
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen-DR13 and DR15 are associated with short-term lung transplant outcomes.
Gracon AS; Liang TW; Rothhaar K; Wu J; Wilkes DS
J Surg Res; 2016 Jun; 203(1):82-90. PubMed ID: 27338538
[TBL] [Abstract][Full Text] [Related]
12. Development of bronchiolitis obliterans syndrome despite blood chimerism in human lung transplant recipients.
Calhoun R; SivaSai KS; Sundaresan S; Trulock EP; Lynch JP; Patterson GA; Cooper JD; Mohanakumar T
Transpl Int; 1999; 12(6):439-46. PubMed ID: 10654356
[TBL] [Abstract][Full Text] [Related]
13. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
[TBL] [Abstract][Full Text] [Related]
14. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.
Morrell MR; Pilewski JM; Gries CJ; Pipeling MR; Crespo MM; Ensor CR; Yousem SA; D'Cunha J; Shigemura N; Bermudez CA; McDyer JF; Zeevi A
J Heart Lung Transplant; 2014 Dec; 33(12):1288-94. PubMed ID: 25443870
[TBL] [Abstract][Full Text] [Related]
15. De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation.
Safavi S; Robinson DR; Soresi S; Carby M; Smith JD
J Heart Lung Transplant; 2014 Dec; 33(12):1273-81. PubMed ID: 25130554
[TBL] [Abstract][Full Text] [Related]
16. HLA mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation.
Peltz M; Edwards LB; Jessen ME; Torres F; Meyer DM
J Heart Lung Transplant; 2011 Apr; 30(4):426-34. PubMed ID: 21145259
[TBL] [Abstract][Full Text] [Related]
17. Influence of HLA Mismatching on Survival in Lung Transplantation.
Hayes D; Whitson BA; Ghadiali SN; Tobias JD; Mansour HM; Black SM
Lung; 2015 Oct; 193(5):789-97. PubMed ID: 26220289
[TBL] [Abstract][Full Text] [Related]
18. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
[TBL] [Abstract][Full Text] [Related]
20. Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation.
Schulman LL; Weinberg AD; McGregor C; Galantowicz ME; Suciu-Foca NM; Itescu S
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1833-7. PubMed ID: 9620914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
